The Deafness Gene Panel by NGS / EDTA Blood is a comprehensive genetic test designed to identify gene mutations associated with hereditary and early-onset hearing loss. It uses advanced Next-Generation Sequencing to screen multiple genes linked to congenital and progressive deafness. Metropolis Healthcare performs this test with high-precision genomic technology to provide reliable insights for diagnosis and clinical decision-making. It is especially valuable for individuals with unexplained hearing loss or a family history of auditory disorders.
Price:
Rs. 21,000.00
Sample Type: EDTA Blood
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the Deafness Gene Panel by NGS include?
This panel at Metropolis Healthcare screens multiple genes known to cause hereditary or early-onset hearing loss.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses advanced Next-Generation Sequencing to analyze DNA extracted from an EDTA blood sample.
Who should take this test?
Individuals with congenital hearing loss, progressive hearing issues, or a family history of deafness may benefit from this test at Metropolis Healthcare.
Why is genetic testing important for hearing loss?
Metropolis Healthcare offers this test to identify underlying genetic causes that guide treatment, prognosis, and family planning.
What sample is required for the test?
An EDTA blood sample is used at Metropolis Healthcare for detailed genetic analysis.
Do I need any special preparation?
No special preparation is needed; Metropolis Healthcare handles all sequencing procedures after sample collection.
How long do results take?
Metropolis Healthcare typically provides results within a clinically appropriate timeframe for NGS-based genetic panels.
Can this test guide treatment or counseling?
Yes, Metropolis Healthcare’s results help doctors recommend interventions, hearing-support strategies, or genetic counseling.